Research Based Professional Formulas







CoQ10 90 DRcaps


Intestinal Release

CoQ10 75 mg

Pyridoxyl 5’ Phosphate

90 DRcaps

NPN 80040942

view label

View the Ad

(2 DRCaps)
Coenyme Q10 (CoQ10)
75 mg 150 mg
Pyridoxyl 5' Phosphate (PLP) 5 mg 10 mg
Phosphatidylcholine 400 mg 800 mg

Recommended dose:

Adults: Take 2 DRcaps daily, one with the morning meal and one with the evening meal, or as directed by a health care practitioner.

Recommended use or purpose:

Cautions and warnings:

Coenzyme Q10 (150 mg)

Coenzyme Q10 (CoQ10), is a fat soluble anti-oxidant nutrient that is found in a variety of foods in relatively small quantities. The typical daily dietary intake ranges between 3-5 mg; mainly from meat, fish and poultry.1 The amounts provided from the diet are quite low and far from the amounts required for therapeutic effects.

CoQ10 is an integral component of oxidative phosphorylation. The mitochondria of cells require CoQ10 to convert energy from food into the main cellular fuel known as adenosine triphosphate (ATP).

CoQ10 may help the heart during times of stress by improving cardiac energy utilization. CoQ10 acts as an antioxidant due to its capacity to increase endogenous (internally produced) antioxidant enzymes and reduce lipid peroxidation (damage to lipids and fatty cell membranes).

Favourable modifications in plasma lipid concentrations are linked to the intake of CoQ10, thereby reducing potential risk.

Clinical evidence shows that supplemental intake of CoQ10 benefits conditions associated with cellular energy and antioxidant abnormalities (including mitochondrial encephalomyopathies, myoclonic epilepsy with lactic acidosis and stroke like episodes, Kearns-Sayre syndrome, etc.) and congestive heart failure.3,4 Improvements in blood pressure and protection from myocardial infarctions have also been associated with supplementation of CoQ10.5,6

Preliminary evidence shows that CoQ10 may be beneficial for the management of diabetes; however, research is still warranted to confirm this effect.

Daily supplements of CoQ10 may boost antioxidant defences and reduce markers of oxidative stress in people with atherosclerosis, or hardening of the arteries.

According to a new study from Taiwan published in the October, 2011 edition of Nutrition titled “Coenzyme Q10 supplementation reduces oxidative stress and increase antioxidant enzyme activity in patients with coronary artery disease”.

The authors reported: “A daily CoQ10 dose of 150 mg was associated with 29% lower levels of malon-dialdehyde (MDA - a reactive carbonyl compound and a well-established marker of oxidative stress) after eight weeks, compared with the placebo group”.


Given the therapeutic potential of CoQ10, supplemental forms are being explored for maximum bioavailability. Typical pre-supplemental plasma concentrations of CoQ10 in healthy adults range between 0.50-0.52 micrograms/ml. Three months of supplemental intake (120 mg daily) can potentially elevate these levels three fold.8

DRcaps Improve Absorption

Vitex’s CoQ10 formula is provided in the new DRcaps; DRcaps technology enables the enzyme to pass through the stomach unchanged, and be absorbed in the small intestine. 

DRcaps have many advantages over the traditional enteric coating of tablets and capsules. This new technology eliminates the costly enteric coating process which requires the use of solvents and heat which can have destructive effect on the active ingredients in the formula.  

DRcaps are resistant to moisture and provide a more precise and consistent dissolution rate compared to traditional enteric coated capsules or tablets.

Bio-availability Co-factors

The fat soluble nature of CoQ10 requires dietary fat to promote its absorption. Lipids associated with fat soluble nutrients induce the release of bile and promote emulsification (micelle suspensions) to facilitate absorption via the small intestine.9

A recent study shows that CoQ10 in an oil suspension gave better bio-availability; likely due to its fat soluble nature.7 Naturally occurring emulsifiers, such as phosphatidylcholine (lecithin) are known to support this process.

Phosphatidylcholine (800 mg)

A more effective delivery system (release in the small intestine) includes the use of emulsifying agents such as phosphatidylcholine to increase the bio-availability of CoQ10.

It was demonstrated that the bio-availability of sitostanol, a phytosterol compound, was increased when formulated with lecithin.10

Another study showed that absorption of the fat soluble carotenoid lycopene was enhanced with the enteral administration of phosphatidylcholine.11

Pyridoxyl-5'-Phosphate (10 mg)

Pyridoxyl-5'-Phosphate (PLP), the active form of vitamin B6 is included because it further enhances plasma concentrations of CoQ10. PLP is essential to the endogenous (internal) synthesis of CoQ10.

It is known that the endogenous bio-synthesis of CoQ10 from the precursor tyrosine is dependent on adequate PLP levels. Research has found that individuals with low plasma CoQ10 status are also low in plasma PLP.1

Supplemental intake of CoQ10 formulated with phosphatidylcholine and PLP will enhance plasma concentrations of CoQ10 thereby improving its therapeutic action.

DRcaps, plus the combination of nutrients in this formula makes it the most bio-available form of CoQ10 available.

In addition, this combination of nutrients may also help reduce the levels of plasma homocysteine (an independent marker for cardiovascular disease risk), since PLP and phosphatidylcholine support the methylation pathways responsible for lowering homocysteine levels.

NOTE: For maximum benefit, take the SOURCE Optimum, SONA based vitamin/mineral/ enzyme formula and VEGAN Omega 3-6-9 to provide the body with optimum levels of other essential nutrients necessary to help maintain long term good health.

Packaging: Packed in light & oxygen resistant recyclable PETE (Bisphenol A free) bottles. 
Gluten Free: Contains no animal substance, artificial preservatives, colours, flavours, starch, sugar, lactose, dairy, salt, yeast or wheat.
DRcaps: Hypromellose polymer, gellan gum (designed to dissolve in the small intestine)
DRCaps is a reg. trademark of Capsugel.

List of articles for more information.

Physical activity may ward off heart damage
CoQ10 and Migraine Relief
Cardio Boost - The Body's Spark Plug
Mount Sinai Duo uncovering the molecular events underlying infertility
CoQ10 - Improves symptoms of congestive heart failure
CoQ10 - Facts & Fabrications
Coenzyme Q10 decreases all cause mortality by half
First powered study shows CoQ10 can reduce heart failure by half
CoQ10 boosts power in German athletes: Study
CoEnzyme Q-10 Medline Plus
CoQ10 and vitamin B6 levels linked to lower artery disease risk
CoQ10 May Boost Antioxidant Defenses in People with Atherosclerosis
CoQ10 may enhance anti-inflammatory potential of Med diet
Selenium + CoQ10 supplements may slash cardiovascular mortality: RCT


  1. Weber C et al. Coenzyme Q10 in the Diet- Daily Intake and Relative Bioavailability. Mol Aspects Med. 1997; 18 Suppl: S251-4.
  2. Modi K et al. Effect of Coenzyme Q10 on Catalase Activity and Other Antioxidant Parameters in Streptozotocin-Induced Diabetic Rats. Biol Trac Elem Res. 2006 Jan; 109(1):25-34.
  3. Chan A et al. Metabolic Changes in Patients with Mitochondrial Myopathies and Effects of Coenzyme Q10 Therapy. J Neurol. 1998 Oct; 245(10):681-5.
  4. Hofman-Bang et al. Coenzyme Q10 as an Adjunctive in the Treatment of Chronic Congestive Heart Failure. The Q10 Study Group. J Card Fail. 1995 Mar; 1(2): 101-7.
  5. Singh RB et al. Effect of Hydrosoluble Coenzyme Q10 on Blood Pressures and Insulin Resistance in Hypertensive Patients with Coronary Artery Disease. J Hum Hypertens. 1999 Mar; 13(3): 203-8.
  6. Singh RB et al. Effect of Coenzyme Q10 on Risk of Atherosclerosis in Patients with Recent Myocardial Infarction. Mol Cell Biochem. 2003 Apr; 246(1-2): 75-82.
  7. Weis M et al. Bioavailability of Four Oral Coenzyme Q10 Formulations in Healthy Volunteers. Mol Aspects Med. 1994; 15 Suppl: s273-80.
  8. Chopra RK et al. Relative Bioavailability of Coenzyme Q10 Formulations in Human Subjects. Int J Vitam Nutr Res. 1998; 68(2):109-13. Shils ME and Young VR. Modern Nutrition in Health and Disease. Lea and Febiger. 988.
  9. Richard EO et al. Sitostanol Administered in Lecithin Micelles Potently Reduces Cholesterol Absorption in Humans. Am J Clin Nutr. 1999; 70(5): 826-831.
  10. Nishimukai M and Hara H. Enteral Administration of Soybean Phosphatidylcholine Enhances the Lymphatic Absorption of Lycopene, but Reduces That of Alpha-Tocopherol in Rats. J Nutr; 2004; Aug; 134(8): 1862-6.
  11. Willis R et al. Clinical Implications of the Correlation Between Coenzyme Q10 and Vitamin B6 Status. Biofactors. 1999; 9(2-4):359-63.

Back to Products